Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN118737 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Complement Decay-Accelerating Factor (CD55) antibody
- Antibody type
- Monoclonal
- Antigen
- K562 cells
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 67
- Vial size
- 0.2 mg
- Concentration
- 1.0 mg/ml
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf Life: one year from despatch.
Submitted references Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy.
Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.
Decay-accelerating factor: biochemistry, molecular biology, and function.
Cromer-related antigens--blood group determinants on decay-accelerating factor.
Wenzel K, Zabojszcza J, Carl M, Taubert S, Lass A, Harris CL, Ho M, Schulz H, Hummel O, Hubner N, Osterziel KJ, Spuler S
Journal of immunology (Baltimore, Md. : 1950) 2005 Nov 1;175(9):6219-25
Journal of immunology (Baltimore, Md. : 1950) 2005 Nov 1;175(9):6219-25
Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.
Holmes CH, Simpson KL, Wainwright SD, Tate CG, Houlihan JM, Sawyer IH, Rogers IP, Spring FA, Anstee DJ, Tanner MJ
Journal of immunology (Baltimore, Md. : 1950) 1990 Apr 15;144(8):3099-105
Journal of immunology (Baltimore, Md. : 1950) 1990 Apr 15;144(8):3099-105
Decay-accelerating factor: biochemistry, molecular biology, and function.
Lublin DM, Atkinson JP
Annual review of immunology 1989;7:35-58
Annual review of immunology 1989;7:35-58
Cromer-related antigens--blood group determinants on decay-accelerating factor.
Daniels G
Vox sanguinis 1989;56(4):205-11
Vox sanguinis 1989;56(4):205-11
No comments: Submit comment
No validations: Submit validation data